Cas:1459-93-4 Dimethyl isophthalate manufacturer & supplier

Chemical Name:Dimethyl isophthalate

CAS.NO:1459-93-4

Synonyms:dimethyl 1,3-benzenedicarboxylate;isophthalic acid dimethyl ester;Dimethyl m-phthalate;RARECHEM AL BF 0071;Dimethylios-phthalate;METHYL ISOPHTHALATE;1,3-Benzenedicarboxylic acid, dimethyl ester;EINECS 215-951-9;1,3-Benzenedicarboxylic acid dimethyl ester;Morflex 1129;Dimethyl isophthalat;Dimethyl isophthalate;Uniplex 270;MFCD00008433

Molecular Formula:C₁₀H₁₀O₄

Molecular Weight:194.184

HS Code:2917399090

Physical and Chemical Properties:

Melting point:64-68 °C(lit.)

Boiling point:285.0±8.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.515

PSA:52.60000

Exact Mass:194.057907

LogP:2.45

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like dimethyl 1,3-benzenedicarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00008433 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Morflex 1129 Use and application,MFCD00008433 technical grade,usp/ep/jp grade.

Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. Dimethyl isophthalate manufacturer Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. Dimethyl isophthalate supplier The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels. Dimethyl isophthalate vendor The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. Dimethyl isophthalate factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.